ARTICLE | Clinical News
Cobas AmpliPrep/Cobas TaqMan HCV Test v2 regulatory update
March 18, 2013 7:00 AM UTC
Roche said FDA approved its Cobas AmpliPrep/Cobas TaqMan HCV Test v2.0 to determine the amount of HCV RNA for assessing virologic response to antiviral therapy. Roche expects to launch the test "short...